Phreesia (PHR) Stock Forecast, Price & News

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PHR shares.
View PHR analyst ratings or view top-rated stocks.

12 Wall Street analysts have issued 12 month price targets for Phreesia's shares. Their PHR share price forecasts range from $30.00 to $43.00. On average, they anticipate the company's stock price to reach $37.92 in the next year. This suggests a possible upside of 17.5% from the stock's current price.
View analysts price targets for PHR or view top-rated stocks among Wall Street analysts.

Phreesia's stock was trading at $32.36 at the beginning of 2023. Since then, PHR shares have decreased by 0.2% and is now trading at $32.28.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 6th 2023.
View our PHR earnings forecast.

Phreesia, Inc. (NYSE:PHR) posted its quarterly earnings results on Wednesday, May, 31st. The company reported ($0.70) earnings per share for the quarter, topping the consensus estimate of ($0.80) by $0.10. The firm had revenue of $83.85 million for the quarter, compared to analyst estimates of $80.64 million. Phreesia had a negative trailing twelve-month return on equity of 53.25% and a negative net margin of 53.89%. During the same period in the prior year, the business earned ($0.99) EPS.

ETFs with the largest weight of Phreesia (NYSE:PHR) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Invesco DWA Healthcare Momentum ETF (PTH), SPDR FactSet Innovative Technology ETF (XITK), BlackRock Future Innovators ETF (BFTR), First Trust Small Cap Growth AlphaDEX Fund (FYC), Invesco DWA SmallCap Momentum ETF (DWAS) and

Phreesia updated its FY 2025 earnings guidance on Sunday, June, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $500.00 million-$500.00 million, compared to the consensus revenue estimate of $453.08 million.

172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA).

(PHR) raised $127 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray served as the underwriters for the IPO.

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

Phreesia's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (13.34%), BlackRock Inc. (8.42%), Brown Advisory Inc. (6.05%), Credit Suisse AG (3.64%), Granahan Investment Management LLC (2.79%) and Jennison Associates LLC (2.58%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Chaim Indig, Charles Kallenbach, Cheryl Pegus, Daniel Nathan, David Linetsky, Edward L Cahill, Edward L Cahill, Evan Roberts, Gillian Munson, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub, Randy Rasmussen and Thomas Altier.
View institutional ownership trends.

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PHR stock can currently be purchased for approximately $32.28.

Phreesia (NYSE:PHR) has a market capitalization of $1.73 billion and generates $280.91 million in revenue each year. The company earns $-176,150,000.00 in net income (profit) each year or ($3.07) on an earnings per share basis.

The company employs 1,546 workers across the globe.

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The official website for the company is www.phreesia.com. The company can be reached via phone at (888) 654-7473, via email at investors@phreesia.com, or via fax at 646-607-1776.